VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
about
Ultrasound molecular imaging: Moving toward clinical translationFemale Reproductive System and Immunology.Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K/AKT/MAPK signaling pathways.Improved Sensitivity in Ultrasound Molecular Imaging With Coherence-Based Beamforming
P2860
VEGFR2-Targeted Ultrasound Imaging Agent Enhances the Detection of Ovarian Tumors at Early Stage in Laying Hens, a Preclinical Model of Spontaneous Ovarian Cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
VEGFR2-Targeted Ultrasound Ima ...... of Spontaneous Ovarian Cancer.
@en
VEGFR2-Targeted Ultrasound Ima ...... of Spontaneous Ovarian Cancer.
@nl
type
label
VEGFR2-Targeted Ultrasound Ima ...... of Spontaneous Ovarian Cancer.
@en
VEGFR2-Targeted Ultrasound Ima ...... of Spontaneous Ovarian Cancer.
@nl
prefLabel
VEGFR2-Targeted Ultrasound Ima ...... of Spontaneous Ovarian Cancer.
@en
VEGFR2-Targeted Ultrasound Ima ...... of Spontaneous Ovarian Cancer.
@nl
P2093
P2860
P356
P1433
P1476
VEGFR2-Targeted Ultrasound Ima ...... of Spontaneous Ovarian Cancer.
@en
P2093
Animesh Barua
Aparna Yellapa
Janice M Bahr
Pincas Bitterman
Sameer Sharma
Sanjib Basu
Sergio A Machado
P2860
P304
P356
10.1177/0161734614553603
P577
2014-10-06T00:00:00Z